Physician profile
Zoie Walker
NPI 1679131304
$1,277.17
in general payments reported to CMS, 2019-2025
15 companies · $76.24 in 2025
The $76.24 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $33.92 · 2023: $625 · 2024: $542 · 2025: $76.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,243.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $360.95 | 2023-2025 | Vraylar, Qulipta, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $275.74 | 2023-2024 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $209.22 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.53 | 2023 | Jardiance |
| Lilly USA, LLC | $65.00 | 2023 | Mounjaro, Trulicity, Jardiance |
| Pfizer INC. | $52.91 | 2023 | |
| Exact Sciences Corporation | $33.98 | 2024 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $33.94 | 2023 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.76 | 2022-2023 | Xifaxan |
| Astellas Pharma US INC | $30.50 | 2023 | Veozah |
| Glaxosmithkline, LLC. | $23.80 | 2023 | Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $23.09 | 2024 | Rexulti |
| Sumitomo Pharma America, INC. | $20.69 | 2023 | Gemtesa |
| Biohaven Pharmaceutical Holding Company LTD. | $19.25 | 2022 | |
| Inspire Medical Systems, INC. | $13.81 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zoie Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.